Rationale: Carnitine palmitoyltransferase (CPT) II is one of a pivotal enzyme in mitochondrial fatty acid oxidation, which is essential for energy production during simultaneous glucose sparing and a requirement for major energy supply, such as prolonged fasting or exercise. When infants require more energy than provided by the glycolytic system, they rely on the mitochondrial fatty acid oxidation pathway. Mutations of the CPT2 gene have been reported to cause sudden unexpected death in infancy (SUDI). A thermolabile phenotype of a CPT2 polymorphism (F352C) has been recently reported to reduce CPT II enzyme activity. The F352C variant results in energy crisis at high temperature and is suspected as a risk factor for acute encephalopathy. However, a relationship between CPT2 gene polymorphism and SUDI has not been described. Methods: Single nucleotide polymorphisms of the CPT2 gene were investigated among 54 SUDI cases and 200 healthy volunteers. Results: The frequency of the C allele was significantly higher in the SUDI group than in the control group [25.0% vs 16.0%, odds ratio (OR) = 1.75, 95% confidence interval (CI) = 1.05-2.92, p = 0.030). The frequency of the F352C homozygote was significantly higher in the SUDI group than in control group (11.1% vs 3.5%, OR = 3.45, 95% CI = 1.11-10.73, p = 0.036). Conclusion: The F352C CPT2 variant might be a genetic risk factor for SUDI.
Introduction
Mitochondrial fatty acid oxidation is essential for energy production during conditions requiring simultaneous glucose sparing and a major energy supply, such as prolonged fasting or exercise. An essential step in fatty acid oxidation is played by the carnitine palmitoyltransferase (CPT) enzyme system, which transfers longchain fatty acids containing P16 carbons (C16, C18:1, C18:2, and C18) from the cytosolic compartment to the mitochondrial matrix, where b-oxidation takes place. The CPT enzyme system consists of several mitochondrial membrane-bound enzymes: CPT I, CPT II (EC 2.3.1.21), and carnitine-acylcarnitine translocase. CPT II is located on the inner aspect of the inner mitochondrial membrane and converts long-chain acylcarnitines to long-chain acyl-CoAs [1] [2] [3] .
